NCT06476873

Substance Use Disorder in Chemsex Practice

Substance Use Disorder in Chemsex Practice: Evaluation of the Prevalence of the Disorder Among Users Via an Online Self-questionnaire

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 1,000 (estimated)
• Sponsor: Centre Hospitalier Charles Perrens, Bordeaux · Other Government
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The main aim of this descriptive cross-sectional study is to assess the prevalence of chemsex substance use disorder among chemsexers via an online self-questionnaire.

Detailed description

Chemsex appeared in Europe around 2006 and in France in 2010. It involves the use of psychoactive substances in a sexual context to enhance, initiate, facilitate or prolong sexual intercourse through the psychoactive effects of the molecules consumed. These molecules are essentially synthetic cathinones, GHB/GBL, MDMA, methamphetamines, cocaine and ketamine. These products are often used in combination with erectile dysfunction treatments (side effects of the molecules). This practice is thought to affect almost 20% of MSM. This use has numerous social, somatic, psychiatric and addictive consequences. Studies have mainly focused on infectious risks, psychiatric complications (e.g. anxiety and depression) or the prevalence of this phenomenon. However, no study has assessed the prevalence of chemsex-related substance use disorders among these users.

Conditions

• Addiction Chemical
• Use, Substance

Interventions

Type	Name	Description
BEHAVIORAL	Online self-questionnaire.	Descriptive, cross-sectional study This study is aimed at adult chemsex users over the last 12 months (having experimented with chemsex at least once over the last 12 months) and with a good understanding of French. An online LimeSurvey-type self-questionnaire will be accessible via a URL link to collect and secure the data. A presentation of the study, information on chemsex and help and care services, as well as the information note will be available. The questionnaire will be distributed via a QR code, giving direct access to the study's web page, or directly via the web link. Posters and flyers will be used in hospitals and/or private clinics, addictology centers, STI prevention and screening centers and associations, as well as via social networks, dating apps and sites, and the online and print press.

Timeline

• Start date: 2024-07-01
• Primary completion: 2025-04-30
• Completion: 2025-08-30
• First posted: 2024-06-27
• Last updated: 2024-06-27

Locations

1 site across 1 country: France